Claus Asbjørn Andersson
Chief Executive Officer bij Sunstone LSV Special Limited Partner III Aps
Oorsprong van het eerstegraads netwerk van Claus Asbjørn Andersson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
22
| Public Company | Pharmaceuticals: Major | 22 |
Sunstone Capital A/S
 Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors.
20
| Private Company | Investment Managers | 20 |
17
| Public Company | Medical Specialties | 17 |
| Public Company | Biotechnology | 12 | |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark.
9
| Subsidiary | Biotechnology | 9 |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.
9
| Subsidiary | Medical Specialties | 9 |
FBC Device ApS
 FBC Device ApS Medical SpecialtiesHealth Technology FBC Device ApS provides spinal implants for the treatment of degenerative disc disease. Its products include Statur-L. The firm develops and manufactures healthcare equipment that helps in the placement of spine in correct position after an implant surgery. The company was founded by Finn Bjarke Christensen in 2005 and is headquartered in Risskov, Denmark.
7
| Private Company | Medical Specialties | 7 |
Acarix A/S
 Acarix A/S Medical SpecialtiesHealth Technology Acarix A/S engages in development, production and advertisement of a new cardiovascular diagnostic methods and equipment. It develops engages in the non-invasive and non-radiation acoustic detection of coronary artery disease. The firm designs CADScor, a sensor that records, processes, and displays heart signal. The company was founded in 2009 and is headquartered in Kongens Lyngby, Denmark.
6
| Subsidiary | Medical Specialties | 6 |
ReWind Therapeutics NV
 ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Sunstone LSV General Partner BI ApS
2
| Private Company | 2 | |
Sunstone LSV Management A/S
2
| Subsidiary | 2 | |
Sunstone LSV General Partner I ApS
2
| Private Company | 2 | |
Sunstone LSV Invest III ApS
1
| Private Company | 1 | |
Sunstone LSV Special Limited Partner III Aps
1
| Private Company | 1 | |
Sunstone Life Science Ventures A/S
 Sunstone Life Science Ventures A/S Financial ConglomeratesFinance Part of Sunstone Capital A/S, Sunstone Life Science Ventures A/S is a Danish company that provides investment services. The private company is based in Copenhagen, Denmark.
1
| Subsidiary | Financial Conglomerates | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Claus Asbjørn Andersson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| NICOX SA | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| ACTIVE BIOTECH AB | Biotechnology | Chief Executive Officer Investor Relations Contact Corporate Officer/Principal | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark. | Investment Managers | Head-Equity Investments Head-Equity Investments Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Chief Investment Officer Private Equity Investor | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
| University of Aarhus | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree | |
| University of Lund | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| MENTICE AB | Medical Specialties | Chairman Director/Board Member | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Private Equity Investor Director of Investments | |
Freespee AB
 Freespee AB Miscellaneous Commercial ServicesCommercial Services Freespee AB provides call-based advertising technology and services. It focuses on driving performance based inbound sales calls to advertisers from online and mobile media. The firm’s partner network includes agencies, local advertising publishers, as well as affiliate and mobile networks. The company was founded by Carl Holmquist and Tobies Lindgren in 2008 and is headquartered in Uppsala, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Reapplix A/S
 Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Director/Board Member Director/Board Member Director/Board Member | |
JenaValve Technology, Inc.
 JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Director/Board Member Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Heartcore Capital A/S | Investment Managers | Founder Founder Private Equity Investor Director/Board Member Private Equity Investor Director of Finance/CFO | |
Zhuhai Seine Technology Co., Ltd.
 Zhuhai Seine Technology Co., Ltd. Computer PeripheralsElectronic Technology Zhuhai Seine Technology Co., Ltd. is a holding company that manufactures printers and supplies printer consumables. It offers single funcation and multifunction printers, printer cartridges such as inkjet, laser and ribbon, and packaging . The company was founded by Jackson Wang on April 24, 2006 and is headquartered in Zhuhai, China. | Computer Peripherals | Director/Board Member Director/Board Member | |
| DEXTECH MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
Rigontec GmbH
 Rigontec GmbH Pharmaceuticals: MajorHealth Technology Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| TME PHARMA N.V. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Nuevolution A/S
 Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Peakon ApS
 Peakon ApS Miscellaneous Commercial ServicesCommercial Services Peakon ApS develops an application software. The firm offers platform with real time people analytics dashboard, scheduling, monitoring, personalized insights, secure access and record employee feedback. The company was founded by Christian Holm, Dan Rogers, Kasper Hulthin and Phil Chambers in 2015 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Sunstone LSV Special LP II Holding Aps | Director/Board Member Director/Board Member | ||
| Sunstone LSV Gp I Holding ApS | Director/Board Member Director/Board Member | ||
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Scenic Biotech BV
 Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chief Investment Officer Corporate Officer/Principal | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
| Eir Ventures Danmark ApS | Investment Managers | Private Equity Investor Private Equity Investor | |
Corlieve Therapeutics SAS
 Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Denemarken | 24 |
| Zweden | 12 |
| Verenigde Staten | 6 |
| Frankrijk | 4 |
| Duitsland | 4 |
Sectoraal
| Health Technology | 25 |
| Commercial Services | 8 |
| Consumer Services | 8 |
| Finance | 7 |
| Miscellaneous | 2 |
Operationeel
| Director/Board Member | 730 |
| Corporate Officer/Principal | 172 |
| Chairman | 148 |
| Chief Executive Officer | 107 |
| Independent Dir/Board Member | 89 |
Sterkste connecties
| Insiders | |
|---|---|
| Peter James Arthur Benson | 58 |
| Gunnar Magnus Modee Persson | 51 |
| Ulf Rosén | 45 |
| Viktor Drvota | 41 |
| Nikolaj Nyholm | 39 |
| Søren Lemonius | 39 |
| Peter Barrett | 38 |
| Jack Nielsen | 38 |
| Jørgen Smidt | 36 |
| Stéphane Verdood | 32 |
| Stephan Christgau | 29 |
| Joseph deBethizy | 29 |
| Sten Verland | 28 |
| Patrick van Beneden | 28 |
| Jimmy Fussing Nielsen | 27 |
- Beurs
- Insiders
- Claus Asbjørn Andersson
- Bedrijfsconnecties
